Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -579.89% is 301% below its 5-year average of -144.76%, around the middle of its 5-year range (-1384.56%–-32.61%).
As of the fiscal period ended Tuesday, June 30, 2026. 110.62% below its 12-month average of -275.32%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -579.89%.
RETURN ON INVESTED CAPITAL (ROIC)
-579.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-275.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-214.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-144.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-91.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-76.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-110.62%
CURRENT VS 3Y AVG
-170.61%
CURRENT VS 5Y AVG
-300.59%
CURRENT VS 10Y AVG
-530.90%
CURRENT VS 15Y AVG
-662.09%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-1526.16%
vs the sector median at left
VivoSim Labs, Inc.
Market Cap
$518606.00
Return on Invested Capital (ROIC)
-579.89%
TTM Avg
-275.32%
3Y Avg
-214.29%
5Y Avg
-144.76%
Market Cap
$545796.00
Return on Invested Capital (ROIC)
-41.92%
TTM Avg
-267.75%
3Y Avg
-175.00%
5Y Avg
-127.51%
Market Cap
$481786.00
Return on Invested Capital (ROIC)
-71.43%
TTM Avg
-135.62%
3Y Avg
-128.99%
5Y Avg
-103.99%
Market Cap
$403887.00
Return on Invested Capital (ROIC)
-10.38%
TTM Avg
-17.82%
3Y Avg
-53.65%
5Y Avg
-61.91%
Market Cap
$378849.00
Return on Invested Capital (ROIC)
-83.46%
TTM Avg
-94.98%
3Y Avg
-93.88%
5Y Avg
-93.88%
Market Cap
$667469.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-19.74%
3Y Avg
-21.30%
5Y Avg
-19.67%
Market Cap
$716854.00
Return on Invested Capital (ROIC)
4.47%
TTM Avg
-1129.41%
3Y Avg
-780.32%
5Y Avg
-986.52%
Market Cap
$250443.00
Return on Invested Capital (ROIC)
-152.82%
TTM Avg
-117.29%
3Y Avg
-102.27%
5Y Avg
-113.28%
Market Cap
$824550.00
Return on Invested Capital (ROIC)
-343.55%
TTM Avg
-272.49%
3Y Avg
-270.70%
5Y Avg
-191.72%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | $518606.00 | -579.89% | -275.32% | -214.29% | -144.76% |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -41.92% | -267.75% | -175.00% | -127.51% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | -71.43% | -135.62% | -128.99% | -103.99% |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | -10.38% | -17.82% | -53.65% | -61.91% |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | -83.46% | -94.98% | -93.88% | -93.88% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A | -19.74% | -21.30% | -19.67% |
| CDT Equity Inc. (CDT)vs › | $716854.00 | 4.47% | -1129.41% | -780.32% | -986.52% |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | -152.82% | -117.29% | -102.27% | -113.28% |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | -343.55% | -272.49% | -270.70% | -191.72% |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A | -3.54% | -13.19% | -11.55% |
ROIC
-579.9%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -579.89% |
| 2026-03-31 | -249.66% |
| 2025-12-31 | -255.38% |
| 2025-09-30 | -168.19% |
| 2025-06-30 | -123.47% |
| 2025-03-31 | -115.61% |
| 2024-12-31 | -1384.56% |
| 2024-09-30 | -294.24% |
| 2024-06-30 | -191.97% |
| 2024-03-31 | -336.07% |
| 2023-12-31 | -275.30% |
| 2023-09-30 | -203.41% |
| 2023-06-30 | -143.90% |
| 2023-03-31 | -106.54% |
| 2022-12-31 | -50.06% |
| 2022-09-30 | -45.27% |
| 2022-06-30 | -41.55% |
| 2022-03-31 | -35.97% |
| 2021-12-31 | -36.76% |
| 2021-09-30 | -32.61% |
| 2021-06-30 | -44.47% |
| 2021-03-31 | -42.93% |
| 2020-12-31 | -82.50% |
| 2020-09-30 | -99.38% |
| 2020-06-30 | -71.57% |
| 2020-03-31 | -80.64% |
| 2019-12-31 | -88.91% |
| 2019-09-30 | -78.03% |
| 2019-06-30 | -65.69% |
| 2019-03-31 | -73.94% |
| 2018-12-31 | -76.35% |
| 2018-09-30 | -73.93% |
| 2018-06-30 | -77.95% |
| 2018-03-31 | -78.09% |
| 2017-12-31 | -77.91% |
| 2017-09-30 | -75.96% |
| 2017-06-30 | -68.93% |
| 2017-03-31 | -61.07% |
| 2016-12-31 | -50.66% |
| 2016-09-30 | -69.69% |
| 2016-06-30 | -69.94% |
| 2016-03-31 | -61.25% |
| 2015-12-31 | -55.30% |
| 2015-09-30 | -45.53% |
| 2015-06-30 | -37.90% |
| 2015-03-31 | -62.18% |
| 2014-12-31 | -60.00% |
| 2014-09-30 | -49.93% |
| 2014-06-30 | -53.22% |
| 2014-03-31 | -42.76% |
| 2013-12-31 | -36.92% |
| 2013-09-30 | -31.34% |
| 2013-06-30 | -206.40% |
| 2013-03-31 | -133.60% |
| 2012-09-30 | -79.29% |
| 2012-06-30 | -31.77% |
| 2012-03-31 | -13.35% |
